RICHMOND, Va.--(BUSINESS WIRE)--U.S. Smokeless Tobacco Company, Altria Group, Inc.’s (Altria) smokeless tobacco business, has submitted to the Food and Drug Administration (FDA) a Modified Risk Tobacco Product application for its Copenhagen® Snuff Fine Cut moist smokeless tobacco product.
Altria aspires to be the U.S. leader in authorized, non-combustible, reduced-risk products. This action furthers Altria’s plan for submitting reduced-harm product applications with the FDA on a range of non-combustible tobacco products. FDA will now undertake an administrative review to determine whether to accept the application for substantive review.
Altria’s Profile
Altria’s wholly-owned subsidiaries include Philip Morris USA Inc., U.S. Smokeless Tobacco Company LLC, John Middleton Co., Sherman Group Holdings, LLC and its subsidiaries, Nu Mark LLC, Ste. Michelle Wine Estates Ltd. and Philip Morris Capital Corporation. Altria holds an equity investment in Anheuser-Busch InBev SA/NV.
The brand portfolios of Altria’s tobacco operating companies include Marlboro®, Black & Mild®, Copenhagen®, Skoal®, MarkTen® and Green Smoke®. Ste. Michelle produces and markets premium wines sold under various labels, including Chateau Ste. Michelle®, Columbia Crest®, 14 Hands® and Stag’s Leap Wine Cellars™, and it imports and markets Antinori®, Champagne Nicolas Feuillatte™, Torres® and Villa Maria Estate™ products in the United States. Trademarks and service marks related to Altria referenced in this release are the property of Altria or its subsidiaries or are used with permission. More information about Altria is available at altria.com and on the Altria Investor app.
